NEW YORK, NY / ACCESSWIRE / May 29, 2018 / OPEC and major oil-producer Russia were considering an increase in supply, pressuring energy stocks lower. U.S. markets however posted weekly gains on Friday, buoyed by strong performance from the technology shares. The Dow Jones Industrial Average dropped 0.24 percent to close at 24,753.09, while the S&P 500 Index declined 0.24 percent to close at 2,721.33. The Nasdaq Composite Index increased 0.13 percent to close at 7,433.85. For the week, Dow and S&P gained a modest 0.2 percent and 0.3 percent respectively while Nasdaq closed with a strong gain of 1.1 percent.
"If the Saudis do lift oil production, that could be the news of the day. It may result in a weak patch for the energy sector, but for the broader market that could be offset by a rise in sentiment if it results in gas prices falling going into the summer driving season," said John Augustine, chief investment officer at Huntington Private Bank.
RDI Initiates Coverage on:
Tesaro's stock jumped 6.55% Friday, to close the day at $51.76. The stock recorded a trading volume of 1,268,605 shares, which was above its three months average volume of 1,185,503 shares. In the last year, Tesaro's shares have traded in a range of 44.76 - 168.92. The share price has gained 15.64% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $50.65 is below its 200-day moving average of $65.27. Shares of Tesaro have fallen roughly 1.52 percent in the past month and are down 37.54 percent year-to-date.
Access RDI's Tesaro, Inc. Research Report at:
On Friday, shares of TherapeuticsMD recorded a trading volume of 4,531,761 shares, which was above the three months average volume of 2,340,751 shares. The stock ended the day 5.09% higher at $6.40. The share price has fallen 8.7% from its 52-week high with a 52-week trading range of 3.83 - 7.01. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $5.81 is above its 200-day moving average of $5.76. Shares of TherapeuticsMD have gained roughly 14.9 percent in the past month and are up 5.96 percent year-to-date.
Access RDI's TherapeuticsMD, Inc. Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.